vTv Therapeutics Inc. Made Big Gain
Wed, Jun 01, 2022 at 05:30 PM
vTv Therapeutics Inc. (VTVT:NASDAQ) soared at $0.72, a gain of 30.6%. On Tue, May 31, 2022, VTVT:NASDAQ touched a New 2-Week High of $0.55. The stock appeared on our News Catalysts scanner on Wed, Jun 01, 2022 at 07:15 AM in the 'AGREEMENT' category. From Tue, May 17, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
About vTv Therapeutics Inc. (VTVT:NASDAQ)
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.
Top 10 Gainers:
- Missfresh Limited (MF:NASDAQ), 51.05%
- Spark Networks SE (LOV:NASDAQ), 38.39%
- Energy Focus, Inc. (EFOI:NASDAQ), 37.42%
- View Inc. (VIEW:NASDAQ), 33.07%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 31.48%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 30.62%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 29.1%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 25.58%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 21.23%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 19.76%